Cargando…
L-Arginine-eNOS-NO Functional System in Brain Damage and Cognitive Impairments in Cerebral Small Vessel Disease
Cerebral small vessel disease (CSVD) is a significant cause of cognitive impairment (CI), disability, and mortality. The insufficient effectiveness of antihypertensive therapy in curbing the disease justifies the search for potential targets for modifying therapy and indicators supporting its use. U...
Autores principales: | Dobrynina, Larisa A., Shabalina, Alla A., Shamtieva, Kamila V., Kremneva, Elena I., Zabitova, Maryam R., Krotenkova, Marina V., Burmak, Anastasiia G., Gnedovskaya, Elena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572456/ https://www.ncbi.nlm.nih.gov/pubmed/37833984 http://dx.doi.org/10.3390/ijms241914537 |
Ejemplares similares
-
The Predictive Value of Salt Sensitivity and Osmotic Fragility in the Development of Cerebral Small Vessel Disease
por: Dobrynina, Larisa A., et al.
Publicado: (2020) -
Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease
por: Dobrynina, Larisa A., et al.
Publicado: (2019) -
Daily blood pressure profile and blood–brain barrier permeability in patients with cerebral small vessel disease
por: Dobrynina, L. A., et al.
Publicado: (2022) -
MRI Types of Cerebral Small Vessel Disease and Circulating Markers of Vascular Wall Damage
por: Dobrynina, Larisa A., et al.
Publicado: (2020) -
Microstructural Predictors of Cognitive Impairment in Cerebral Small Vessel Disease and the Conditions of Their Formation
por: Dobrynina, Larisa A., et al.
Publicado: (2020)